EQ

Equillium
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.840
-0.274
-6.65%
Closed 16:00 12/06 EST
OPEN
4.250
PREV CLOSE
4.114
HIGH
4.265
LOW
3.840
VOLUME
19.95K
TURNOVER
--
52 WEEK HIGH
16.40
52 WEEK LOW
2.555
MARKET CAP
64.12M
P/E (TTM)
-2.8552
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of EQ and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 4 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

EQ News

  • Equillium to Present Translational Data on Itolizumab for Acute Graft-Versus-Host Disease at 61st American Society of Hematology (ASH) Annual Meeting and Exposition
  • GlobeNewswire.11/26 21:07
  • Equillium Featured in Panel Discussion at Capital Markets Day for Kidney Health
  • GlobeNewswire.11/15 13:05
  • Equillium S-3 Shows $250M Mixed Securities Offering
  • Benzinga.11/13 22:27
  • Equillium Q3 EPS $(0.35) Up From $(0.44) YoY
  • Benzinga.11/12 21:10

More

Industry

Pharmaceuticals
+0.11%
Pharmaceuticals & Medical Research
+0.32%

Hot Stocks

Name
Price
%Change

About EQ

Equillium, Inc. is a biotechnology company. The Company develops products for severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need. Its initial product candidate, EQ001 (itolizumab), is a clinical-stage, monoclonal antibody that selectively targets the novel immune checkpoint receptor CD6. CD6 plays a central role in the modulation of effector T cells, or Teff cells. Activated Teff cells drive a number of immuno-inflammatory diseases across therapeutic areas including transplant science, systemic autoimmunity, pulmonary, neurologic, gastrointestinal, renal, vascular, ophthalmic and dermatologic disorders. EQ001, disease modifying treatment for multiple severe immuno-inflammatory disorders. It plans to initiate a Phase Ib/II clinical trial of EQ001 for the treatment of acute graft-versus-host disease, or aGVHD.
More

Webull offers Equillium Inc (EQ) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.